tiprankstipranks
pc:omnix

Omnix Medical

Omnix Medical is a biopharmaceutical company focused on developing next-generation anti-infectives to combat life-threatening infections, particularly those caused by drug-resistant bacteria. Founded in 2015, the company specializes in engineered antimicrobial peptides, with its lead compound, OMN6, designed to target and destroy bacterial cell membranes, offering a novel approach to treating multidrug-resistant infections. Omnix Medical's innovative solutions aim to address the global crisis of antibiotic resistance, supported by significant funding and strategic partnerships.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$25M
Latest Funding Amount$25M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 15, 2025
Series C
$25.00M

Investors

Investor Name
Funding Round

Related News and Analysis